Log in  First Connection?

Schizophrenia: Archives News of the month

Resource deprivation in the home environment is associated with negative symptoms in outpatients with Schizophrenia
Schizophrenia
 2 min.

 Published on 08/04/2025 |  Original article (Abstract)  | Luther Lauren et al. | Schizophrenia 2025; 11(1): 56

Negative symptoms—reductions in goal-directed behavior, social motivation, experience of pleasure, speech output and intonation, and emotional expressions—are a key factor underlying the poor functional outcomes observed in schizophrenia (SZ)1. Although promising treatments have been developed2,...

Population Pharmacokinetic Modeling of TV-46000, a Risperidone Long-Acting Subcutaneous Antipsychotic for the Treatment of Patients with Schizophrenia
Schizophrenia
 6 min.

 Published on 01/04/2025 |  Original article (Abstract)  | Itay Perlstein et al. | Neurology and Therapy 2025; aop: 10.1007/s40120-025-00723-z

TV-46000 is a long-acting subcutaneous antipsychotic (LASCA) agent that combines risperidone and an innovative, copolymer-based drug delivery technology in a suspension suitable for subcutaneous (sc) administration from a prefilled syringe (PFS) [1, 2]. Other risperidone formulations include R064766...

Common and unique white matter fractional anisotropy patterns in patients with schizophrenia with medication-resistant auditory verbal hallucinations: a retrospective tract-based spatial statistics study
Schizophrenia
 8 min.

 Published on 25/03/2025 |  Original article (Abstract)  | Zhuo Chuanjun et al. | Schizophrenia 2025; 11(1): 46

Auditory verbal hallucinations (AVHs) are reported by 70–80% of patients with schizophrenia1, and approximately 20–40% of these patients demonstrate an unfavorable response to available antipsychotic medications2,3. These medication-resistant AVHs markedly interfere with normal social function...

Altered serum glutathione disulfide levels in acute relapsed schizophrenia are associated with clinical symptoms and response to electroconvulsive therapy
Schizophrenia
 5 min.

 Published on 18/03/2025 |  Original article (Abstract)  | Xu Li et al. | BMC Psychiatry 2025; 25(1): 242

Schizophrenia is a severe mental disorder with a global prevalence of approximately 1%, characterized by positive symptoms, negative symptoms, and cognitive impairment [1]. This disorder significantly diminishes the quality of life of patients, while imposing substantial disease burdens on families and...

Weaker beta desynchronization indicates impaired emotion recognition in schizophrenia
Schizophrenia
 5 min.

 Published on 11/03/2025 |  Original article (Abstract)  | Csukly Gábor et al. | Schizophrenia 2025; 11(1): 39

Schizophrenia is a disorder characterized by positive, negative, and cognitive symptoms—that affects about 1% of the population worldwide. Emotional recognition deficit is also a well-known symptom of schizophrenia, which is present at the onset of the mental disorder1 and can highly affect the...